Reported alterations in T reg cells from type 1 diabetes (T1D) patients led us to a revision of their phenotypical features compared with controls. A fine cytometric analysis was designed for their characterization, using a panel of markers including FOXP3, CTLA4, glucocorticoid-induced TNFR family related (GITR) and CD127. The frequency of peripheral CD4 +
Introduction
Autoimmunity is caused by the disruption of mechanisms involved in the maintenance of peripheral tolerance. The existence of thymus-derived T cells with suppressor properties was suggested in the late 1960s by transfer experiments of thymus CD4 + T cells that conferred protection from autoimmunity (1) . The absence of a specific marker was always a disadvantage to further characterize these cells, until the demonstration by Sakaguchi et al. (2) in 1995 that T cells with regulatory properties expressed CD25 (IL-2Rα chain) constitutively. CD4 + CD25
bright T reg cells constitute 5-10% of peripheral CD4 + T cells in healthy mice and humans. These cells are thymus emigrants selected by high-affinity TCRligand interactions (3) and are called natural T reg (nT reg ) cells to distinguish them from peripherally induced T reg -cell subsets generated during the immune response [induced T reg (iT reg ) cells]. Functionally, T reg cells are activated by TCR signaling, do not secrete IL-2 and suppress effector T-cell (T eff cell) proliferation. The role of T reg cells in the development of autoimmunity was further demonstrated by the description of the genetic defect of 'scurfy' mice (4). Mutations in the foxp3 gene, which encodes a forkhead/winged helix transcription factor, impair T reg -cell maturation in the thymus of these mice and their absence is responsible for autoimmune lymphoproliferative disease. A defective expression of FOXP3 has also been demonstrated in a human syndrome of similar clinical features named IPEX (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) (5) . FOXP3 is the 'master regulator' gene, constitutively expressed by nT reg cells (6) . CD4 + CD25
bright T cells with high regulatory function are also characterized by low expression of CD127 (IL-7Rα chain) in contrast to naive T cells or effector-memory T cells (7) , which makes T reg cells more dependent on IL-2 for maintenance. Other markers with increased expression in T reg cells are glucocorticoid-induced TNFR family related (GITR) (8) , CTLA4, CD122, CD62L and CD45RO (9) , but their expression is not exclusive. Even FOXP3 is up-regulated in human CD4 + T cells after activation and it is related with the acquisition of suppressor function (10) . iT reg cells also decrease the expression of CD127 after activation. Therefore, it is almost impossible to distinguish natural from induced CD4 + CD25 + FOXP3 + T cells. Currently, the only specific feature that distinguishes them is the presence of a specific unmethylated region at the FOXP3 gene promoter (11) .
Several studies have been conducted to find a connection between T reg cells and human autoimmunity, in most cases searching for altered number or function of T reg cells from PBMC of patients with different autoimmune diseases (12) (13) (14) . Regarding type 1 diabetes (T1D), several works have been performed with non-conclusive results ranging from reduced T reg -cell frequency (15) or function (16, 17) to no differences, when comparing diabetic with healthy control subjects (18) . Schneider et al. (19) first reported that T eff cells from T1D patients were refractory to suppression by both selfantigen-induced and nT reg cells. However, later on Long et al. (20) found that antigen-specific iT reg cells from controls and T1D patients suppressed similarly. Alternatively, the profound IL-2 dependence of T reg cells has encouraged other authors to study the involvement of the IL-2 signaling pathway in T reg cells of T1D subjects. Long et al. (21) found alterations in the IL-2 signaling pathway in both nT reg and iT reg cells from T1D patients. In addition, a correlation between a single-nucleotide polymorphism in the IL2RA region and lower production of soluble CD25 has been established in T1D (22) . Thus, T reg cells play a role in human T1D though the underlying mechanism is still undefined.
Here, we report a very detailed study by flow cytometry of the T reg -cell population, together with other CD4 + T-cell subsets from PBMC of a cohort of T1D patients at onset, compared with healthy donors. A decrease of the whole CD4 +
CD25
+ T cells was found in T1D patients. Further characterization of the T reg -cell phenotype showed a lower percentage of GITR + cells, accompanied by a decreased GITR expression level, in T1D patients' T reg cells compared with controls, which was maintained after their in vitro expansion in sub-optimal stimulation conditions. However, when assaying their regulatory capacity, expanded T1D T reg -cell-mediated suppression was as efficient as that by control T reg cells. No evidence of a total T reg -cell decrease was observed in patients, but the yield of sorted T reg cells was significantly lower in patients than in controls. Co-stimulatory and anti-apoptotic roles have been described for GITR in T cells. Our data indicate that patients' T reg cells are more susceptible to apoptosis than T reg cells from controls, both after activation and in non-stimulating culture conditions. Thus, GITR would be primarily involved in T reg -cell survival, rather than in their suppressor function.
Methods

Patients
A total of 117 heparinized blood samples were analyzed for the study: healthy control subjects (n = 46), T1D patients (n = 40) and Graves-Basedow disease (GD) patients (n = 31) who were included as autoimmune controls (Table 1) . Blood samples from all study subjects were taken after signing the informed consent approved by the ethical committee of the relevant institutions. All patients were bled at the time of disease onset, before receiving any treatment.
Antibodies
FITC-conjugated CD4 (clone SK3); PE-conjugated CD8 (SK1), CD122 (TU27), CD95 (DX2), CD45RO (UCHL-1), CD62L (SK11), CCR4 (1G1), CCR5 (2D7), CD54 (HA58), CD127 (hIL-7R-M21) and CD152 (BNI3); PE-CyChrome5 (PE-Cy5)-conjugated CD25 (M-A251) and PE-Cy7-conjugated CD4 (SK3) were purchased from BD Pharmingen (San Jose, CA, USA). PE-conjugated GITR (110416) and PE-FOXP3 (PCH101) were purchased from R&D Systems (Minneapolis, MN, USA) and eBiosciences (San Diego, CA, USA), respectively. The isotype controls were purchased to BD Bioscience (San Jose, CA, USA).
Cell staining and flow cytometry analysis
For surface staining, 200 μl of fresh blood from each sample were directly stained with anti-CD4-FITC, anti-CD25-PECy5.5 and the PE-labeled marker antibodies. After 30 min of incubation, RBCs were lysed with FACS lysis solution diluted 1:10 (BD Bioscience), incubated for 10 min and washed in PBS with 2% of FCS (Invitrogen, Carlsbad, CA, USA). For cytoplasmic staining of FOXP3 and CTLA4, cells were washed once with 0.1% saponin (Sigma-Aldrich, St Louis, MO, USA) in PBS with 2% of FCS and re-suspended in 50 μl of permeabilization solution (0.3% saponin in PBS with 2% of FCS) in the presence of the PE-labeled antibody. After 45 min of incubation, cells were washed in PBS and fixed with lysis solution. All incubation steps were performed at room temperature in the dark. Acquisition was performed in a FACSCalibur flow cytometer (BD Immunocytometry Systems) and data were analyzed using the CellQuest software on the basis of a modified version of Wing et al. (9) . CD4 T lymphocytes were gated both by their side-and forward-scatter properties (R1) and by their CD4 high expression (R2). To define CD25 + (R3) from CD25 − cells (R4), a control tube with only CD4 staining was used. Then, the slight decrease in CD4 mean fluorescence intensity (MFI) by T reg cells was used to differentiate the CD25 low (R5) from the CD25 bright (R6) fractions. To further define T reg cells, R6 was subdivided into CD25 med (R8) and Low GITR + in T1D T reg cells 565 CD25 hi (R7) fractions. The CD25 hi population was those cells that fell outside from the main cell population in the dot plot (see Fig. 1A ). 
Gene expression analysis
Expansion of T reg -and T eff -cell populations
PBMC from control and T1D individuals were FACS-sorted to obtain the CD4 +
CD25
bright and CD4 + CD25 − T-cell populations. Rapid expansion method (REM) (25) was adapted as follows: 40 000 cells of each sorted T-cell population were cultured in T25 flasks (BD Bioscience) containing 25 ml of IMDM media supplemented with 2 mM l-glutamine, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin (all from Sigma-Aldrich), 10% human serum and 50 ng ml −1 OKT3 antibody with 25 × 10 6 30 Gy-irradiated-autologous PBMC as feeders. IL-2 was added at day 1 at 100 and 45 U ml −1 for T reg and T eff cells, respectively. Cells remained untouched during the first 5 days of culture, and then cells were split every 3-4 days. Cells were stained and cryopreserved for later use at days 9 and 15.
Suppression assays
Thawed expanded T reg -cell populations from control and T1D samples were cultured in round-bottomed 96-well plates at different ratios with 10 000 thawed magnetic-sorted allogeneic CD4 + CD25
− T cells per well. T eff cells were stimulated using anti-CD3-/anti-CD28-coated beads (cells:bead ratio 2:1) (Dynabeads, Life Technologies, Carlsbad, CA, USA) in the presence of autologous-irradiated PBMC (5 × 10 4 cells per well). As a control for the assay, proliferation of each separated population (1 × 10 4 cells per well) was calculated using the same conditions. Plates were incubated for 5 days at 37°C and 5% CO 2 . Cells were pulsed with 1 μCi per well of 3 [H]-methyl-thymidine (Perkin-Elmer, Waltham, MA, USA) 16 h before harvesting. Percent suppression was calculated as follows: 100 − (100 × c.p.m. ratio T reg :T eff cells per c.p.m. T eff cells). All culture conditions were performed in triplicate.
Apoptosis assays
For activation-induced cell death, expanded T reg and T eff cells from controls (n = 3) and patients (n = 4) were activated in vitro with 1.25 μl anti-CD3-/anti-CD28-coated beads (Invitrogen) per million cells (cells:bead ratio 2:1) and IL-2 at 100 U ml −1 and cultured for 3 days in IMDM media supplemented with 2 mM l-glutamine, 100 U ml −1 penicillin and 100 μg ml −1 streptomycin (all from Sigma-Aldrich) and 10% human serum. Then, cells were plated at 10 5 cells per well into a flat-bottomed 96-well plate and cultured with medium alone or proapoptotic stimulus such as plate-bound anti-CD3 mAb OKT3 (pb-OKT3) at 30 μg ml −1 or soluble anti-CD95 mAb (DX2) at 1 μg ml −1 , in complete IMDM media containing IL-2 at 100 U ml −1 . Apoptosis was analyzed at 24, 48 and 72 h of culture using the Annexin-V-FLUOS Staining Kit (Roche Diagnostics GmbH, Mannheim, Germany), following the manufacturer's instructions. No washing steps were performed.
Statistical analysis
Data were analyzed using the ANOVA one-way variance test followed by the post-hoc Tukey-Kramer analysis to study differences between groups. Student's t-test was applied when only two parameters were analyzed. Data from apoptosis assay were analyzed using the ANOVA two-way variance test followed by the post-hoc Bonferroni analysis. + T cells containing effector-memory T cells, we drew on the CD4 MFI decline observed for the T reg -cell subset. After the analysis of >100 samples from controls and patients, we could experimentally establish that the mean relation between MFI CD4 of CD25 + and CD25 bright was 1.2 (Fig. 1A) . The R6 population was further separated on the basis of the CD25 expression in R7 and R8. Thus, CD4 + T cells were separated as total CD4 + CD25 + (CD25T, R3), CD25 lo (R5), CD25 med (R8) and CD25 hi (R7) (see Methods). GD patients' samples were analyzed in parallel, for comparison with another organ-specific autoimmune disease.
Results
Total
The percentage of CD25T from T1D and GD patients' samples (25.6 ± 8.9% and 27 ± 8.5%, respectively) was significantly lower than in controls' (32 ± 9.0%; P < 0.002). However, this effect resulted from the decrease of the CD4 + T cells (G1) were gated according to their side-and forward-scatter properties together with the CD4 staining level. The R4 gate for CD25 − cells was defined by staining with anti-CD4-FITC and PE-and PE-Cy5-isotype antibodies. Total CD25 + cells (CD25T, R3) were defined by staining with anti-CD4-FITC, PE-isotype and anti-CD25-PECy5.5 antibodies. The slight decrease in the CD4 MFI was used to define CD25 lo (R5) and CD25 bright (R6) fractions. R6 was further subdivided into CD25 hi (R7, events outside the main population) and CD25 med (R8) fractions. (B) The frequency of the CD25 populations was analyzed in controls and patients, and there was a statistically significant decrease of the CD25T (P < 0.002) and CD25 lo (P < 0.002) in T1D and GD patients compared with controls, but not in the CD25 bright populations. The ANOVA one-way variance test was applied followed by a post-hoc Tukey-Kramer analysis. (C) CD25 bright and CD25 lo T cells from T1D and control samples were sorted. The yield of sorted T reg cells was statistically lower (P < 0.003) in T1D compared with controls, whereas the count in total PBMC was not. Student's t-test was applied for statistical analysis. **P < 0.01. Low GITR + in T1D T reg cells 567 fraction (26.8 ± 8.5% for controls, 20.6 ± 7.6% for T1D and 22.2 ± 8.0% for GD; P < 0.002) (Fig. 1B) . No differences were found on the T reg cells, probably due to the low percentage observed in periphery. But when T reg cells (CD4 + CD25 bright ) from seven T1D patients' and six control samples were sorted for functional and RNA expression analysis, interestingly, the yield of T reg cells obtained from equal samples of 50 ml of blood was significantly lower in patients versus controls (Fig. 1C) .
Decreased circulating CD4
+ CD25 + GITR + T
cells in T1D patients
To better define T reg cells, other markers were studied including surface CD122, CD95, CD45RO, CD62L, CCR4, CCR5, GITR, CD54 and CD127, and cytoplasmic CTLA4 (CD152) and FOXP3 (Supplementary Figure 1 is available at International Immunology Online). The high expression of FOXP3 and CD152 and the low expression of CD127 in T reg cells were confirmed in patients and controls. Otherwise, the only significant difference concerned GITR (Fig. 2) . The percentage of GITR + cells was significantly reduced in the CD25 hi population from T1D patients (32.6 ± 11 in T1D versus 45.2 ± 15.7 in controls; P < 0.0009) and to a lesser extent in the CD25 med (P < 0.01) and CD25 lo (P < 0.02) cell fractions. Analysis of GITR expression in the CD25 cell fractions from representative control and T1D donors is shown in Supplementary  Figure 2 (available at International Immunology Online). GITR expression in GD patients did not differ from healthy donors, suggesting that this phenotype was specific for T1D T cells.
To further analyze if this reduced frequency was accompanied by a decrease in the level of GITR expression, the MFI of GITR was measured in controls and diabetic patients at the single-cell level (Fig. 3) . GITR MFI was significantly diminished in the whole CD4 + CD25 + T cell from T1D patients versus controls (Fig. 3A) , and this decrease was observed also in all CD25 fractions (Fig. 3B) . Again, the major significant difference was found in the CD25 hi cells from T1D patients (32.5 ± 6 in T1D versus 39.4 ± 6 in controls; P < 0.001).
To analyze these differences at the mRNA level, GITR quantitative PCR was performed using sorted CD4 + CD25 bright fractions from patients' and controls' PBMC. The results showed lower GITR mRNA level in five out of seven of T1D patients compared with the average value of four control samples. In contrast, FOXP3 expression was equivalent to controls (Fig. 4) . Statistics applied to GITR and FOXP3 values determined that their expression behavior was significantly different (P < 0.01). ) from T1D (n = 4) and control (n = 4) PBMC were expanded in vitro using the REM described for T-cell culture (25) in the presence of soluble anti-CD3, IL-2 and irradiated autologous feeders (see Methods). With this method, T reg cells could be expanded from 3-4 × 10 4 up to 500 times in 9 days. GITR was analyzed in expanded T-cell populations by flow cytometry on days 9 and 15 of culture. To control for the cell phenotype during the in vitro expansion, CTLA4 and FOXP3 expression were also determined (Fig. 5) . Our data showed that GITR was up-regulated upon stimulation of both T reg and T eff cells, but the positive cell numbers reached in T1D T regcell cultures were significantly lower than in controls (82.3% ± 7.7 in controls versus 58.2% ± 12.1 in T1D; P < 0.05). This tendency was maintained at day 15 although it did not reach significance. No differences were found for GITR MFI (data not shown). These results were confirmed by quantitative PCR (Supplementary Figure 3 is available at International Immunology Online). The levels of FOXP3 remained very low in the T eff -cell fractions at both time points, whereas CTLA4 was high for T eff and T reg cells after 9 days in culture, but after 15 days, CTLA4 levels were maintained at high levels only in T reg cells and not in T eff cells. The percentages of FOXP3 + and CTLA4 + cells were statistically different between the expanded T reg -and T eff -cell fractions at both time points, showing that the expansion method used maintained the phenotype of the initial sorted cells.
Low percentage of GITR + T cells is maintained after in vitro expansion of T reg cells from T1D patients
Low percentage of GITR + cells did not affect the suppression capacity of expanded T1D T reg cells
To test if the reduction of GITR + cells in the patients' expanded T reg cells affected their regulatory capacity, suppression assays were conducted. As responder T cells (T eff ), magnetically sorted CD4 + CD25
− cells were isolated from healthy donors' allogeneic PBMC. T reg cells from 9 and 15 days of culture from T1D (n = 2) and control (n = 2) samples were mixed with T eff cells in the presence of anti-CD3-/anti-CD28-coated beads in a suppression assay at different T reg :T eff cell ratios as shown in Fig. 6 . Equal levels of suppression were achieved by expanded T reg cells from control and T1D samples at both time points. Thus, we have adapted a very efficient method for expanding T reg cells and demonstrated that REM-expanded T reg cells from T1D patients can suppress at similar levels as control T reg cells. We found equal suppression capacity in both groups in spite of the fact that in these activation conditions, GITR + cells were reduced in T1D compared with controls, as shown in Fig. 5 .
Low GITR + cells in T1D CD25
++
FOXP3 + T cells are maintained in short-term culture under sub-optimal stimulation
To test the expression of GITR and T reg -cell survival in short-term culture under full or sub-optimal stimulation, thawed PBMC were maintained in culture for 96 and 120 h with anti-CD3-/ anti-CD28-coated beads or without external stimulus, only with culture medium (Fig. 7) . In medium, only CD25 bright cells expressed GITR, in contrast to fully activated cells that up-regulated GITR to a maximum (Fig. 7A) . After 7 days of culture in these suboptimal stimulation conditions, CD25 bright cells were all FOXP3 + and expressed high levels of GITR (Fig. 7B) . When comparing T1D and control PBMC, the increase of GITR expression after short-term full TCR activation was identical in both groups of samples. However, under sub-optimal culture conditions, this increase of GITR expression was lower in T1D than in controls although not statistically significant, repeating the observed tendency in PBMC and long-term expanded T cells (Fig. 7C) . These sub-optimal stimulation conditions resulted in a decrease of CD25 lo cells and an evident increase of CD25 bright cells, both in patients and controls. The expression of GITR by these two populations again followed the same pattern of ex vivo analyzed cells: only the CD25 bright fraction was GITR + in both groups but with significantly lower levels in patients' versus controls (P < 0.05) (Fig. 7D ). These data suggest that when faced to a sub-optimal stimulus, the cells with a FOXP3 + GITR + regulatory phenotype are maintained in culture, but with lower numbers in T1D patients.
Expanded T1D CD25 ++ FOXP3 + T cells are more susceptible to apoptosis than their control counterparts
To test whether the reduction of GITR was related to its anti-apoptotic function, we stimulated expanded T regs from patients and controls for 3 days with anti-CD3-/anti-CD28-coated beads and then the cells were incubated with apoptotic stimuli, pb-OKT3, anti-CD95 or medium alone. Results are shown in Fig. 8 . As a rule, T reg cells from patients were more susceptible to CD95-mediated apoptosis induction than control T reg cells. Average difference was near 2× at earlier times (24 h) and tended to converge after 48 (1.3×) and 72 h (equal values). The behavior of the curves was statistically significant between controls and patients (P < 0.03) showing the same tendency in all experiments performed (n = 3). These differences were independent of the cells' CD95 expression levels that were identical in the expanded T reg cells (data not shown), as well as in PBMC (Fig. 2) , from patients and controls. Interestingly, the increase of apoptosis in patients' T reg cells respect to controls was also significant when cells were cultured in medium for 72 h (increase 2.7×; P < 0.05), without any specific apoptotic stimulus, suggesting that it might also apply to the homeostatic survival of T1D + T-cell fractions from T1D patients compared with controls. When comparing the expression of T reg -cell markers between samples, the only significant differences concerned GITR in T1D patients versus controls. The frequency of GITR + cells from T1D patients was significantly reduced in all CD25 + fractions, but the reduction in the CD25 hi population was highly significant (P < 0.0009). Statistics were performed using the ANOVA one-way variance test followed by a post-hoc Tukey-Kramer analysis. *P < 0.05; **P < 0.01; ***P < 0.001. Controls, white boxes; GD, light grey boxes; T1D, dark grey boxes.
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T reg cells. Both T reg populations were resistant to apoptosis mediated by TCR signaling, using pb-OKT3, as reported previously (26) . In contrast, expanded T eff were highly susceptible to both TCR-and CD95-mediated apoptosis induction without significant differences between patients and controls (data not shown).
Discussion
In this study, we report a consistent decrease of the GITR + cell frequency in the circulating T reg cells (CD4 + CD25 bright ) of T1D patients compared with control samples, as well as in in vitro-expanded T reg cells in the presence of soluble anti-CD3 or under a weak stimulus. In addition, T reg cells from patients showed higher susceptibility to CD95-mediated apoptosis than controls. This suggested that T1D T reg cells behaved differently than control T reg cells, although the low presence of GITR appeared to affect cell survival rather than suppressor function. Besides, we have adapted the REM method for T reg cells with a high recovery rate and a good maintenance of the regulatory function. Thus, REM culture could be a useful method to expand functional T reg cells for immunotherapy.
The aim of this study was to characterize the CD4 + CD25 bright T reg cells from the peripheral blood of T1D patients. Several groups had analyzed the frequency of total CD4 + CD25 + T cells from PBMC of T1D patients (15, 17, 18, 27, 28) . Kukreja et al. (15) first showed that the number of circulating CD4 + CD25 + T cells was significantly lower in new-onset patients compared with controls and the same tendency was described by Michalek et al. (27) . In the same context, Jin et al. (29) showed a lower frequency of CD25 + T cells in T1D patients over 14 years old versus controls, not in younger patients. Our results confirmed that for adult T1D and also GD patients, the total CD25 + cell numbers were lower than in controls. bright T reg cells in the pancreatic lymph nodes of T1D compared with controls, but no differences were found for the peripheral T reg -cell compartment. A possible explanation for the low number of circulating CD4 + CD25 + T cells in T1D patients is the poor T-cell activation described for patients (30) , in strong correlation with susceptibility genotypes at the IL2RA region and with low levels of soluble CD25 (22) . In the same context, a constitutive defect in CD3/TCR transduction signals that increase sensitivity to apoptosis or anergy has been described for T1D patients (32) .
We analyzed several activation and T reg -cell markers in CD4 + T-cell fractions. Comparative analysis of marker expression showed no difference between controls and patients' GITR MFI was significantly reduced in the CD25T (P < 0.001), and in all fractions, that is, CD25 lo (P < 0.01), CD25 med (P < 0.01) and CD25 hi (P < 0.001) from patients versus controls. Statistics were performed using the ANOVA one-way variance test followed by a posthoc Tukey-Kramer analysis. **P < 0.01; ***P < 0.001. -sorted fractions from PBMC of T1D patients (n = 7) and controls (n = 4). FOXP3 expression was also tested as an experimental control (T1D: n = 5; C: n = 4). The −2 ∆∆Ct method was used to determine the relative quantification values and normalization was performed with RPLO as a housekeeping gene. Relative GITR and FOXP3 expression in patients versus controls was calculated using a reference control value. This reference is the calculated average Ct result for each target gene in control samples and is given an arbitrary value = 1 (filled circle). Relative expression of GITR was found reduced 2-fold in average for five of seven T1D T reg -cell samples. No differences were found for FOXP3 expression. Student's t-test was applied to GITR and FOXP3 values showing that their expression behavior was significantly different (P < 0.01).
T reg cells other than for GITR, a member of the TNFR family described in 1997 (33) . GITR is preferentially expressed by the T reg -cell population of resting CD4 lymphocytes and has been considered as a T reg -cell marker. On the other hand, expression of GITR is up-regulated in all T lymphocytes upon activation (34, 35 lo T cells from newly diagnosed T1D children showed a reduction in GITR, ICOS and CTLA4 mRNA (36) . Therefore, our data demonstrate that in T1D T reg cells, there is a lower level of GITR expression and a lower percentage of GITR + cells. This decrease in GITR did not correlate with the presence of anti-islet or anti-GAD antibodies in these patients (data not shown).
To analyze whether the reduction in GITR + cells was maintained in in vitro-expanded T cells from T1D, we adapted the REM method (25) for T reg cells. This method is very useful for amplifying a very small and highly purified initial T-cell population up to 500-1000-fold in 15 days, using a high number of autologous feeder cells and a sub-optimal concentration of − cells from controls and T1D patients at 9 (top panels) and 15 days of culture (bottom panels). The frequency of GITR + cells in the CD25 + from T1D was significantly reduced when compared with control CD25 + (P < 0.05) after 9 days of culture but did not reach significance after 15 days. Significant differences were also found for intra-cytoplasmic markers FOXP3 and CTLA4 between expanded CD25 + and CD25 − cells fractions at both time points. Statistics were performed using the ANOVA one-way variance test followed by a post-hoc Tukey-Kramer analysis. Outliers were excluded from the analysis. *P < 0.05; **P < 0.01; ***P < 0.001. lo T reg -cell population was inhibited by an anti-GITR antibody. Despite the low GITR + T reg cells in T1D, in our hands REM-expanded T1D T reg cells were able to suppress allo-T eff -cell proliferation at similar levels as controls in the presence of anti-CD3-/anti-CD28-coated beads. Similar data were reported by Putnam et al. (41) , using expanded T reg cells from T1D patients.
Other roles for GITR signaling in T-cell homeostasis have been studied in mice. On one hand, GITR is a co-stimulatory molecule that induces proliferation in T cells. van Olffen et al. (42) described in vivo balanced proliferation of conventional and T reg cells in transgenic mice expressing GITRL in B cells. Some elements described to be involved in GITR signaling are MS4A4B and MS4A6B molecules, members of a family of four-pass membrane receptors (43) . Its over-expression in a mouse lymphoma cell line resulted in augmented signaling and IL-2 production in response to GITR triggering. Carrier et al. (44) also analyzed GITR co-stimulation in vivo, in this case using a mice model in which GITRL was constitutively expressed in MHC-II + cells. In contrast with the previous results, they observed excessive T-cell activation and multiorganic infiltration. These results together pointed to a clear bright cells were all FOXP3 + and expressed high levels of GITR. (C) The increase of GITR expression after short-term full TCR activation was identical in T1D (n = 7) and control (n = 5) samples. Under sub-optimal culture conditions, this increase of GITR expression was lower in T1D than in controls, although it did not reach statistical significance. (D) In sub-optimal stimulation conditions, only CD25 bright cells increased. Most GITR + cells both in patients and controls were found among CD25 bright cells. GITR + cell frequency in this fraction was statistically lower in T1D versus controls before (P < 0.02) and after 120 h of culture (P < 0.05). Statistics were performed using the ANOVA one-way variance test followed by a post-hoc Tukey-Kramer analysis. Outliers were excluded from the analysis. *P < 0.05; ns (non-significant statistically). In (A) and (B), one representative healthy donor is shown.
Downloaded from https://academic.oup.com/intimm/article-abstract/25/10/563/733258 by guest on 01 January 2019 co-stimulatory role for GITR, but the effect of this signaling depends on the balance between activation and regulation that is taking place in a concrete immune context. In fact, involvement of GITR-GITRL in autoimmunity and inflammation has been described in animal models. Ray et al. (45) worked with a B-cell deficient mouse model prone to autoimmunity and showed that complete B-cell depletion led to overt autoimmunity and reduction in T reg numbers, since B cells maintained homeostasis inducing T reg proliferation through GITR-GITRL ligation. Besides, blocking GITR signaling with GITR-Fc correlates with a reduction in disease severity in the spinal cord injury mice model of inflammation (46) . On the other hand, Nocentini et al. (33) demonstrated that GITR-transfected cells were more resistant to induced apoptosis than untransfected cells. More evidence was found by Spinicelli et al., since they described the interaction of GITR with the intra-cytoplasmic protein Siva, which plays an apoptotic role in virus response and stress situations (47) .
Our results using human PBMC demonstrate a low frequency of GITR + CD25
bright T cells in the T reg -cell population of T1D patients versus controls. When fully stimulated, both T eff and T reg cells up-regulated GITR expression. However, when cells were maintained in culture in conditions of sub-optimal stimulation, in the presence of culture medium containing FCS, only CD25 bright FOXP3
+ T reg cells were maintained and a lower frequency of GITR + cells was still found for T1D compared with controls. These results suggest that the lower frequency of GITR + cells in T1D T reg cells would be involved in preventing their full maintenance. Indeed, the yield of sorted T reg cells from equal amounts of blood from patients and controls was significantly lower in patients. Interestingly, the expansion of T1D and control T reg cells with a highly efficient expansion method (REM) in the presence of a high IL-2 concentration and a sub-optimal stimulus, maintained their suppression capacity and their phenotype, including the low frequency of GITR in T1D. T reg survival upon stimulation in patients and controls was demonstrated by their resistance to apoptosis by TCR signaling using plate-coated anti-CD3 antibodies, as previously described for healthy donors (26) . In contrast, T reg cells from patients were more susceptible to CD95-mediated apoptosis than their control counterparts. There is evidence from previous works associating an increased apoptosis ratio in the T regcell compartment of T1D patients versus controls (48, 49) .
Thus, the reported low frequency of GITR + in T1D could be related to an impairment of T reg -cell survival in patients and hence with a reduction of the total level of T-cell regulation.
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